While Insulet Corporation has overperformed by 0.24%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PODD fell by -40.66%, with highs and lows ranging from $335.91 to $125.82, whereas the simple moving average fell by -23.02% in the last 200 days.
On December 21, 2023, Robert W. Baird Upgraded Insulet Corporation (NASDAQ: PODD) to Outperform. A report published by Morgan Stanley on December 04, 2023, Upgraded its rating to ‘Overweight’ for PODD. Jefferies also Upgraded PODD shares as ‘Buy’, setting a target price of $240 on the company’s shares in a report dated October 02, 2023. Citigroup August 21, 2023d the rating to Buy on August 21, 2023, and set its price target from $273 to $265. Robert W. Baird August 21, 2023d its ‘Outperform’ rating to ‘Neutral’ for PODD, as published in its report on August 21, 2023. Morgan Stanley’s report from May 30, 2023 suggests a price prediction of $343 for PODD shares, giving the stock a ‘Equal-Weight’ rating. Wolfe Research also rated the stock as ‘Peer Perform’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Insulet Corporation (PODD)
Further, the quarter-over-quarter increase in sales is 37.90%, showing a positive trend in the upcoming months.
Insulet Corporation’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of 34.12% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.58, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and PODD is registering an average volume of 902.97K. On a monthly basis, the volatility of the stock is set at 3.33%, whereas on a weekly basis, it is put at 5.42%, with a loss of -16.81% over the past seven days. Furthermore, long-term investors anticipate a median target price of $236.52, showing growth from the present price of $164.00, which can serve as yet another indication of whether PODD is worth investing in or should be passed over.
How Do You Analyze Insulet Corporation Shares?
A giant in the Medical Devices market, Insulet Corporation (PODD) is based in the USA. When comparing Insulet Corporation shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 56.31, there is a growth in quarterly earnings of 509.02%.
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.74%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 102.10% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
PODD shares are owned by institutional investors to the tune of 102.10% at present.
